Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells.

about

Cdc20 overexpression is involved in temozolomide-resistant glioma cells with epithelial-mesenchymal transition.PD98059 impairs the cisplatin-resistance of ovarian cancer cells by suppressing ERK pathway and epithelial mesenchymal transition process.

P2860

Q47648800-553D7738-F654-4C01-990F-F640ECFF8D70 Q50157919-C05EC2CB-0CF7-4C59-9EA5-2A11406F15E6

P2860

Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells.

Item

http://www.wikidata.org/entity/Q52760977

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Hippo pathway contributes to c ...... asopharyngeal carcinoma cells.

@en

Hippo pathway contributes to c ...... asopharyngeal carcinoma cells.

@nl

type

Item

label

Hippo pathway contributes to c ...... asopharyngeal carcinoma cells.

@en

Hippo pathway contributes to c ...... asopharyngeal carcinoma cells.

@nl

prefLabel

Hippo pathway contributes to c ...... asopharyngeal carcinoma cells.

@en

Hippo pathway contributes to c ...... asopharyngeal carcinoma cells.

@nl

P1476

Hippo pathway contributes to c ...... asopharyngeal carcinoma cells.

@en

P2093

Chunsheng Gao

http://www.w3.org/2001/XMLSchema#string

Fei Liu

http://www.w3.org/2001/XMLSchema#string

Haiyu Hong

http://www.w3.org/2001/XMLSchema#string

Rongkai Zhang

http://www.w3.org/2001/XMLSchema#string

Shuo Li

http://www.w3.org/2001/XMLSchema#string

Wei Liao

http://www.w3.org/2001/XMLSchema#string

Xiaomeng Zhang

http://www.w3.org/2001/XMLSchema#string

Yunping Fan

http://www.w3.org/2001/XMLSchema#string

Zhengde Du

http://www.w3.org/2001/XMLSchema#string

Zibin Liang

http://www.w3.org/2001/XMLSchema#string

P2860

The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells

TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway

TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition

Regulation of TAZ in cancer

Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds

Molecular mechanisms of epithelial-mesenchymal transition

The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

Nasopharyngeal carcinoma incidence and mortality in China in 2010.

P304

1601-1610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15384101.2017.1356508

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28749195

http://www.w3.org/2001/XMLSchema#string

P932

5587028

http://www.w3.org/2001/XMLSchema#string

Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells.

about

P2860

P2860

Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932